Matthew M. Walsh - 28 Feb 2024 Form 4 Insider Report for Organon & Co. (OGN)

Role: Chief Financial Officer
Signature: /s/ Faye C. Brown, as Attorney-in-Fact for Matthew M. Walsh
Issuer symbol: OGN
Transactions as of: 28 Feb 2024
Net transactions value: -$205,530
Form type: 4
Filing time: 01 Mar 2024, 16:24:13 UTC
Previous filing: 08 Aug 2023
Next filing: 02 Apr 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	OGN	Common Stock	Options Exercise		+33,044	+63%		85,455	28 Feb 2024	Direct	F1
transaction	OGN	Common Stock	Tax liability	$205,530	-11,393	-13%	$18.04	74,062	28 Feb 2024	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	OGN	Restricted Stock Units	Options Exercise	$0	-33,044	-100%	$0.000000^*	0	28 Feb 2024	Common Stock	33,044		Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each Restricted Stock Unit converts into one share of Organon & Co. common stock.
F2	As previously reported, these Restricted Stock Units vested on December 31, 2023, and shares of Organon & Co. common stock were distributed to the Reporting Person on February 28, 2024.